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Objective: To demonstrate the proportion of anemia and its association with demographic
and clinical characteristics in a representative sample of elderly people from São José dos
Campos, São Paulo.
Methods: Demographic data and blood samples were collected from 398 over 65-year-old
male and female individuals. Anemia was deﬁned as hemoglobin concentration <12 g/dL
in  women and <13 g/dL in men. Anemic and non-anemic groups were compared using the
chi-squared test and a multiple logistic regression model.
Results: The prevalence of anemia was 18.6% (20.8% in men and 17.6% in women). The per-
centages of anemia rose signiﬁcantly across the age groups >75–80, >85–90 and >90–95 years
(p-value = 0.0251). There were no signiﬁcant differences in gender, ethnic background, place
of  residence, years of schooling, income, comorbidities and use of medications. Accord-
ing to gender, the mean hemoglobin concentration and mean corpuscular volume were
11.5  g/dL (range: 8.4–11.9 g/dL) and 90.7 fL (range: 63.0–111.7 fL) for women and 11.9 g/dL
(range: 8.6–12.8 g/dL) and 92.1 fL (range: 59.8–100.1 fL) for men. The great majority of ane-
mia  cases were mild with less than 6% having hemoglobin concentrations below 10.9 g/dL.
Mean corpuscular volume was lower than 80 fL in six cases (8%), between 80 and 100 fL in
65  cases (88%) and higher than 100 fL in three cases (4%).
Conclusion: A total of 18.6% of elderly people from São José dos Campos had mild anemia
with  the majority being normocytic. The percentages of anemia rose as the age increased
demonstrating an association between age and anemia.© 2014 Associac¸ão Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published
by Elsevier Editora Ltda. All rights reserved.
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Introduction
It has been demonstrated that anemia among older people
is associated with a variety of adverse outcomes, including
mortality.1,2 Estimates of the prevalence of anemia in elderly
populations depend on demographic aspects, location and the
health status of the individuals.3
In Brazil there are few studies in this ﬁeld of research. To the
best of our knowledge the prevalence of anemia was well doc-
umented in elderly individuals from only two urban regions
located in the northeastern4 and southern regions.5
Considering the impact of anemia on the aged and the
paucity of comparative data in Brazil, it seems that additional
studies from different regions are needed. The population of
São José dos Campos, the largest city in the Vale do Paraíba
(State of São Paulo), is aging because of lower birth rates
as demonstrated by the evolutionary analysis of its popula-
tion pyramid.6 Therefore, the objectives of this study were to
analyze the prevalence of anemia and its association with
demographic characteristics in a sample of elderly people
from São José dos Campos, southeastern Brazil.
Methods
This study was carried out at the Centro de Hematologia do
Vale (CHV) and the Hospital Pio XII in São José dos Campos.
The study was approved by the Research Ethics Committee
of the Universidade Paulista (# 481190) and all participants
signed written consent forms. According to Brazilian Institute
of Geography and Statistics (IBGE, 2010)7 the estimated num-
bers of elderly residents were 19,619 females and 17,810 males
aged from 60 to 69 years and 14,416 females and 10,061 males
older than 70 years. A sample size of 398 was calculated based
on an estimated prevalence of anemia in older people of 20%,
a 95% conﬁdence interval and a sample error of 5%. The inclu-
sion criteria of the study were over 65-year-old individuals,
both males and females, who had not been transfused with
red blood cells within the previous 12 weeks. A questionnaire
was developed by the CHV regarding demographic and clin-
ical aspects. People were invited to participate in the study
through the local media including newspapers, television and
social networks. One-day events were organized in central
community meeting points of all six urban areas of São José
dos Campos (north, east, center, southeast, south and west);
in these places students, physicians and health professionals
randomly applied the questionnaire to elderly local residents.
In a second phase, the participants were invited to give blood
samples in two clinical biochemistry laboratories in the Hos-
pital Pio XII. Overall, 713 people were interviewed and 415
(58.2%) gave blood samples. The samples were obtained from
the median cubital vein using an evacuated tube system. Vol-
unteers who  did not answer the questionnaire or from whom
an inadequate blood sample was collected were excluded from
the study. The ﬁnal study sample included 398 elderly peo-
ple interviewed between May 2012 and November 2013. The
World Health Organization (WHO) criteria were used to deﬁne
anemia (hemoglobin concentration <12 g/dL in women and
<13 g/dL in men) and assess severity.8 Anemic and non-anemicr. 2 0 1 5;3 7(1):43–47
groups were compared using the chi-squared test and a mul-
tiple logistic regression model; p-values of less than 0.05 were
considered signiﬁcant.
Results
The prevalence of anemia in this sample was 18.6% (20.8%
in men  and 17.6% in women). The percentages of anemia
rose signiﬁcantly across the age groups >75–80, >85–90 and
>90–95 years (p-value = 0.0251). No signiﬁcant differences were
observed for the other variables analyzed in this study (gen-
der, ethnic background, place of residence, years of schooling,
income, comorbidities and use of medications – Table 1).
Hemoglobin concentration and mean corpuscular volume
(MCV) of the anemic group according to gender are shown in
Table 2. Overall, the great majority of anemia cases were mild
with less than 6% having hemoglobin concentrations below
10.9 g/dL. The MCV was lower than 80 fL in six cases (8%),
between 80 and 100 fL in 65 cases (88%) and higher than 100 fL
in three cases (4%).
Discussion
This study has limitations. It was carried out based on cross-
sectional data, and therefore, no cause–effect relationship
could be established. This is only a descriptive study that
reports the proportion and severity of anemia in general.
The overall prevalence of anemia in this series was 18.6%
with a signiﬁcant association being demonstrated between
age and anemia. In a prospective population-based study of all
over 64-year-old residents in Biella (Italy), anemia was found in
11.8% with the prevalence and incidence of anemia increasing
with age.9 In a study performed in Germany, the prevalence
of anemia of participants aged 65 or older was 4.3% again
with the incidence increasing with age.10 A prospective study
conducted in elderly Koreans demonstrated that the overall
prevalence of anemia was 13.6% and a signiﬁcant association
was observed with age.11 Data from the United States pop-
ulation assessed in the Third National Health and Nutrition
Examination Survey (NHANES III) identiﬁed anemia in 10.6%
of people aged 65 years and older; anemia increased with
age reaching the highest prevalence in the 85 years and older
age group.12 On the other hand, data from low and middle-
income countries are sparse. Bryce et al.13 surveyed 10,915
people aged 65 years and over in catchment areas in Cuba,
Dominican Republic, Puerto Rico, Venezuela and Mexico and
found anemia prevalence rates of 19.2%, 37.3%, 32.1%, 9.8%
and 9.2% respectively; in all these countries anemia increased
with age. In a population-based study performed among 392
free-living elderly in south Brazil, the overall prevalence of
anemia was 12.8% and this increased with age.5 Moreover, a
cross-sectional study carried out in Camaragibe (northeastern
Brazil) involving 284 subjects aged 60 years and over showed
that the prevalence of anemia was around 11%.4
Data regarding the proportion of anemia in men  and
women and the relationship between anemia and ethnic
background have also been described.3,12 Although females
predominated in this study, a higher occurrence of anemia
was observed in older men  conﬁrming results previously
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Table 1 – Demographic and clinical characteristics of non-anemic and anemic individuals.
Non-anemic Anemic Total p-Value
n (%) n (%) n (%)
Total 324 (81.4) 74 (18.6) 398 (100)
Gender 0.4881
Male 99 (30.6) 26 (35.1) 125 (31.4)
Female 225 (69.4) 48 (64.9) 273 (68.6)
Age group (years) 0.0251
≥65–70 127 (39.2) 28 (37.8) 155 (38.9)
>70–75 100 (30.9) 14 (18.9) 114 (28.6)
>75–80 38 (11.7) 12 (16.2) 50 (12.6)
>80–85 36 (11.1) 8 (10.8) 44 (11.1)
>85–90 19 (5.9) 8 (10.8) 27 (6.8)
>90–95 3 (0.9) 4 (5.4) 7 (1.8)
>95 1 (0.3) 0 (0) 1 (0.3)
Ethnic background 0.3763
White 275 (84.9) 58 (78.4) 333 (83.7)
Black 17 (5.2) 8 (10.8) 25 (6.3)
Asian 13 (4.0) 2 (2.7) 15 (3.8)
Mulatto 17 (5.2) 5 (6.8) 22 (5.5)
Indigenous 2 (0.6) 1 (1.4) 3 (0.8)
Place of residence 0.6973
Urban 314 (96.9) 73 (98.6) 387 (97.2)
Rural 10 (3.1) 1 (1.4) 11 (2.8)
Years of schooling 0.3667
<1 59 (18.2) 11 (14.9) 70 (17.6)
1–4 52 (16.0) 11 (14.9) 63 (15.8)
>4–8 72 (22.2) 23 (31.0) 95 (23.9)
>8–11 59 (18.2) 16 (21.6) 75 (18.8)
>11 82 (25.3) 13 (17.6) 95 (23.9)
Income (number of minimum wages) 0.9313
1 46 (14.2) 8 (10.8) 54 (13.6)
>1–3 98 (30.2) 23 (31.1) 121 (30.4)
>3–6 111 (34.3) 28 (37.8) 139 (34.9)
>6–9 34 (10.5) 8 (10.8) 42 (10.6)
>9 35 (10.8) 7 (9.5) 42 (10.6)
Comorbidities 0.7944
Chronic systemic hypertension 118 (36.4) 22 (29.7) 140 (35.2)
Chronic systemic hypertension + diabetes mellitus 41 (12.7) 14 (18.9) 55 (13.8)
Chronic kidney disease 10 (3.1) 2 (2.7) 12 (3.0)
Rheumatic disease 20 (6.2) 6 (8.1) 26 (6.5)
Neoplastic diseases (complete remission) 21 (6.5) 4 (5.4) 25 (6.3)
Diabetes mellitus or hypothyroidism 46 (14.2) 10 (13.5) 56 (14.1)
Smoking 16 (4.9) 4 (5.4) 20 (5.0)
Alcohol consumption 11 (3.4) 1 (1.4) 12 (3.0)
Total 283 (87.3) 63 (85.1) 346 (86.9)
Use of medication 0.6664
Yes 255 (78.7) 59 (79.7) 314 (78.9)
No 69 (21.3) 15 (20.3) 84 (21.1)
Table 2 – Hemoglobin concentration (Hb) and mean corpuscular volume (MCV) according to gender for the anemic group.
n % Hb (g/dL) MCV (fL)
Male 26 20.8 11.9 (8.6–12.8) 92.1 (59.8–100.1)
Female 48 17.6 11.5 (8.4–11.9) 90.7 (63.0–111.7)
Total 74 18.6 11.6 (8.4–12.8) 91.1 (59.8–111.7)
Data are expressed as median and range.
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reported3,10,12–14 but different to two studies performed in dif-
ferent regions of Brazil by Barbosa et al.4 and Sgnaolin et al.5
This study found no association with regard to ethnic back-
ground; the ethnic background of patients was to some extent
biased due to the subjectivity of the question. This variable
was studied according to the deﬁnition of each patient with-
out any interference of the health professional who applied
the questionnaire. Thus, some patients reported being white
rather than mulatto but this phenomenon was not clearly
observed for Black and Asian classiﬁcations.
As described before, the lack of association for the place
of residence, years of schooling, income and anemia suggests
that socioeconomic aspects did not play a role in the current
sample.3,12,13
With regard to the cause of anemia, the data of this
study suggest a high proportion of people with unexplained
anemia.12,15 There are some reasons that support this hypoth-
esis. Most people had mild and normocytic anemia (88%) in
contrast to low proportions of both microcytic and macro-
cytic anemia. Moreover, blood smears from people with high
MCVs showed a normal appearance of white cells. These
ﬁndings suggest that the occurrence of anemia may not be
associated with iron, folate or vitamin B12 deﬁciencies. In
addition, considering the similar percentages of chronic sys-
temic hypertension, diabetes mellitus, rheumatic diseases
and kidney diseases between anemic and non-anemic groups,
it is reasonable to believe that the anemia could not be
attributed to chronic disease, inﬂammation or chronic kid-
ney disease. Moreover, since the anemia in this series did
not present with either low leukocyte or low platelet counts
(data not shown), a concurrent association with myelodys-
plastic syndromes was not considered.14,16 In comparison, a
revision of clinical, diagnostic and biological issues related to
anemia and aging as reported by Carmel17 demonstrated a
higher prevalence of mild normocytic anemia and smaller pro-
portion of microcytic anemia; unexplained anemia accounted
for 14–17% of the cases. Data from the NHANES III study3,12
indicated that most occurrences of anemia were mild and
nutrient deﬁciency was observed in one-third, anemia of
chronic disease was present in one-third and unexplained
anemia was observed in one-third. The Italian study9 found
a higher proportion of normocytic anemia and the underly-
ing cause of mild anemia remained unexplained in 26.4% of
the cases. A study performed in Germany10 showed that the
majority of the anemia cases were mild with the following
subtypes: microcytic anemia with iron deﬁciency (19%), ane-
mia  of chronic disease (25%) and unexplained anemia (44%).
The study carried out in Camaragibe (northeastern Brazil)4
reported that the major characteristics of anemia were mild,
with normochromia and normocytosis and a lower preva-
lence of microcytosis. In contrast, the occurrence of anemia
in older people from southern Brazil was associated with
microcytosis and hypochromia.5 Data from Cuba, Dominican
Republic, Puerto Rico, Venezuela and Mexico demonstrated
that most cases of anemia were associated with microcytosis
and nutritional deﬁciency.13 Given that anemia is a multi-
factorial condition, a major problem with interpreting these
reports is that they are extrapolated from local data from spe-
ciﬁc regions and thus most likely reﬂecting the characteristicsr. 2 0 1 5;3 7(1):43–47
of a particular population. To further investigate this matter,
studies incorporating the measurement of serum biochemical
markers such as iron, ferritin, folate, vitamin B12 and creati-
nine should be designed in this region.
Conclusion
This study demonstrates that 18.6% of a representative sam-
ple of community-dwelling elderly people from São José dos
Campos, southeastern Brazil had mild anemia with the great
majority being normocytic. The percentages of anemia rose
across the highest age groups and an association between age
and anemia was demonstrated. With regard to the prevalence
of anemia in the elderly, this series was similar to Cuba but
higher than developed countries and other regions of Brazil.
Both the association between age and anemia and the sub-
stantial proportion of mild normocytic anemia of unexplained
cause are similar to other studies.
Finally, considering the heterogeneity in the distribution
of social and biological risk factors in Brazil, we  believe that
a national survey of the prevalence of anemia in the elderly
may shed some light on this important issue. In addition, a
long-term follow-up of the aged with mild and asymptomatic
anemia may be important to establish whether anemia is a
marker of a more  severe underlying condition.
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